Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
ACCELERATED – MALIGNANT HYPERTENSION Hla Chaw and Jeff Ball A systemic disease characterised by an extreme elevation of blood pressure (mean arterial BP greater than 120 mmHg, persistent diastolic blood pressure exceeding 130 mmHg) associated with acute microvascular damage (bilateral retinal haemorrhage, exudates or papilloedema). This demands emergency treatment and close follow-up care. BACKGROUND Incidence - less than 1% of primary hypertension. Incidence increases with age. RISK FACTORS Male, black race, smoking, oral contraceptive use, low socio-economic status. PRESENTATION Headache, visual loss, neurological deficit, seizures, confusion, coma. Nausea, vomiting. Sudden and marked elevation in blood pressure, diastolic > 130 mmHg. Congestive heart failure. Renal failure. DIFFERENTIAL DIAGNOSIS Acute left ventricular failure. Uraemia from any cause. Cerebrovascular accident. Subarachnoid haemorrhage. Brain tumour. Head injury. Epilepsy (postictal). Collagen diseases. Encephalitis Overdose and withdrawal from narcotics, amphetamines, etc. Hypercalcaemia Acute anxiety with hyperventilation syndrome. INITIAL ASSESSMENT PHYSICAL EXAMINATION Cardiovascular system examination: - Heart rate, BP, cardiomegaly, heart sounds. - Features of heart failure: JVP, pedal oedema, bibasal crackles. Fundoscopy: Haemorrhage, exudate, and papilloedema.. Neurological system examination – Focal neurological deficit. INITIAL INVESTIGATION Urinalysis – Protein, Blood. ECG - LVH, ischaemic changes. CXR - Cardiomegaly, acute pulmonary oedema. U&E - Renal Impairment. FBC – Anaemia. Clotting Screen – DIC. TREATMENT - Lower the diastolic BP to 100 -110mmHg over the first 24 hours. - IV Frusemide 40 -80 mg if there is evidence of acute pulmonary oedema or encephalopathy (refer to management of acute pulmonary oedema). - If no feature of acute pulmonary oedema, IV Labetalol, 20-80mg (bolus) followed by an infusion, 20-200mg / min (increasing every 15 minutes). - Nitroprusside (0.25-10 micro gram/kg/min IV infusion) or Hydralazine (5-10 mg IV over 20 min) in LVF. - GTN infusion (1-10 mg/hr) in LVF or Angina. - Switch to oral medications as BP control improves (refer to BHS guidelines for 'High BP 2004'). MONITORING BP, respiratory rate, oxygen saturation, fundus, neurological signs. Catheterise the bladder, intake-output chart. U&E, FBC, ECG. FURTHER/SPECIALIST MANAGEMENT Admit to medical HDU/ITU. Arterial line, Central venous line. Renal team consultation in ARF (refer to management of acute renal failure).